Enteris BioPharma’s “Feasibility-to-Licensing” Partner, Cara Therapeutics, Initiates Phase 2 Trial of Peptelligence®-Engineered Oral KORSUVA™ for Pruritus in Patients with Atopic DermatitisAllbiopro2019-07-12T09:54:26+09:007월 12th, 2019|
Neurotrope to Present at the Alzheimer’s Association International Conference; Neurotrope President and Chief Scientific Officer, Dr. Daniel L. Alkon, to Receive Cure Coin Award; Design of Confirmatory Phase 2 Trial to be PresentedAllbiopro2019-07-12T09:53:53+09:007월 12th, 2019|
Dr. Joseph Kravitz Successfully Treated Thousands of Patients with 3 Minute ImplantAllbiopro2019-07-12T09:53:17+09:007월 12th, 2019|
NuVasive to Participate as Double Diamond Sponsor at 2019 International Meeting on Advanced Spine TechniquesAllbiopro2019-07-12T09:52:47+09:007월 12th, 2019|
Biohaven’s Rimegepant for Migraines Heads to the FDA for Approval Following Successful TrialAllbiopro2019-07-12T09:52:17+09:007월 12th, 2019|
After High-Profile NASH Failure, Gilead Resets with Renown IHI to Sequence Patient DNAAllbiopro2019-07-12T09:51:45+09:007월 12th, 2019|
WHO Outlines 5-Year International Regulatory Plan to Improve Drug and Medical Product Quality AssuranceAllbiopro2019-07-12T09:51:14+09:007월 12th, 2019|
New Insights into the Vagus Nerve Could Change the Way Diabetes is TreatedAllbiopro2019-07-12T09:50:40+09:007월 12th, 2019|
Scripps Research Snags $129 Million for HIV Vaccine InvestigationAllbiopro2019-07-12T09:50:09+09:007월 12th, 2019|
Clover Therapeutics Launches With Eye on Age-Related Ocular DiseasesAllbiopro2019-07-12T09:49:04+09:007월 12th, 2019|
Reckitt Benckiser Settles Indivior Opioid Investigation for $1.4 BillionAllbiopro2019-07-12T09:48:31+09:007월 12th, 2019|
Developing a Ketone Body-Based Drug to Combat Alzheimer’s DiseaseAllbiopro2019-07-12T09:47:58+09:007월 12th, 2019|
White House Kills Drug Rebate Proposal After ‘Careful Analysis and Thorough Consideration’Allbiopro2019-07-12T09:47:25+09:007월 12th, 2019|
SOTIO Initiates First-In-Human Clinical Trial with IL-15 Superagonist SO-C101Allbiopro2019-07-12T09:46:53+09:007월 12th, 2019|
Pfizer’s Xeljanz drops off top June TV spenders list—and Gilead’s Biktarvy fills the voidAllbiopro2019-07-12T09:46:23+09:007월 12th, 2019|
Sorry, pharma: White House pulls industry’s favored rebate proposalAllbiopro2019-07-12T09:45:49+09:007월 12th, 2019|
Sterile drug maker Nexus launches $250M U.S. manufacturing projectAllbiopro2019-07-12T09:45:13+09:007월 12th, 2019|
